Stephens initiated coverage of TransMedics with an Overweight rating and $151 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX:
- TransMedics price target raised to $120 from $95 at Piper Sandler
- TransMedics price target raised to $117 from $102 at Canaccord
- TransMedics price target raised to $125 from $105 at Oppenheimer
- TransMedics price target raised to $130 from $100 at TD Cowen
- TransMedics Reports First Quarter 2024 Financial Results